Do you want to read an article? Please log in or register.
Background Mucosal Inflammation Affects Colorectal Cancer Prognosis in Ulcerative Colitis: A Nationwide, Multicenter Study
Gastrointestinal CancerInflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN
J Crohns Colitis
Trivić Mažuranić I, Aloi M, Bramuzzo M, Chiantese C, D'Arcangelo G, Gattenlöhner S, Gianolio L, Granot M, Hızarcıoğlu Gülşen H, Hussey S, Kang B, Kolho KL, de Laffolie J, Lega S, Martinelli M, Matar M, Mayer C, Miele E, Norsa L, Panarese I, Rinawi F, Rohani P, Romano C, Sansotta N, Scarallo L, Shouval DS, Staiano A, Strisciuglio C, Tomas D, Yerushalmy-Feler A, Zojaji R, Hojsak I
doi: 10.1093/ecco-jcc/jjag074
Inflammatory Bowel Disease
Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden
Inflamm Bowel Dis
Osooli M, Voghera S, Bruze G, Nordenvall C, Hedin CRH, Everhov ÅH, Myrelid P, Ludvigsson JF, Olén O, SWIBREG Study Group§
doi: 10.1093/ibd/izaf278
Gastrointestinal CancerInflammatory Bowel Disease
Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study
Inflamm Bowel Dis
Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY
doi: 10.1093/ibd/izaf304
Inflammatory Bowel Disease
Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study
J Crohns Colitis
D'Amico F, Fanizzi F, Dal Buono A, Gabbiadini R, Nardone OM, Zilli A, Allocca M, Lauriola GM, Jairath V, Peyrin-Biroulet L, Fiorino G, Castiglione F, Massimino L, Mastronardi M, Armuzzi A, Danese S
doi: 10.1093/ecco-jcc/jjag062
Inflammatory Bowel Disease
Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study
Inflamm Bowel Dis
Ünal NG, Bakkaloğlu OK, Kav T, Eşkazan T, Kani HT, Akpınar A, Akıncıoğlu P, Dağcı G, Şendur İ, Büyüktorun İ, Barutçu S, Kılıç G, Bengi G, Çavuş B, Oruç N, Alahdab YÖ, Atuğ Ö, Dinçer D, Karakan T, Hatemi Aİ, Erzin YZ, Tezel A, Törüner M, Akyüz F, Çelik AF
doi: 10.1093/ibd/izag126
RECOMMENDED
Gastrointestinal Cancer
Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Eur J Cancer
Fournier E, Schaffar R, Staehelin K, Rouxel N, Ris F, Toso C, Frossard JL, Rapiti E, Koessler T, Wildisen L, Meyer J
doi: 10.1016/j.ejca.2026.116707
Inflammatory Bowel Disease
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID
United European Gastroenterol J
Calméjane L, Reenaers C, Gay C, Amiot A, Nuzzo A, Vuitton L, Atanasiu C, Stefanescu C, Altwegg R, Guillo L, Serrero M, Bouguen G, Nachury M, Cosquer GL, Roblin X, Abitbol V, Hammoudi N, Simon M, Fumery M, Savoye G, Benezech A, Cavicchi M, Charkaoui M, Buisson A, Caron B, Coffin B, Geyl S, Goutorbe F, Hupé M, Vidon M, Laharie D, Kirchgesner J, Uzzan M, GETAID‐AFTER‐VEDO Study Group
doi: 10.1002/ueg2.70203
RECOMMENDED
Colonoscopy
Development of the PROMOTE model to stratify colorectal cancer risk for prioritization of colonoscopy resource use: a multicenter prospective study
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Endoscopy
Frazzoni L, Spada C, Manes G, Fabbri C, Di Marco M, Mussetto A, Bertani H, Radaelli F, Hassan C, Antonelli G, Facciorusso A, Dinis-Ribeiro M, Rees CJ, Fuccio L, and the PROMOTE Study Group
doi: 10.1055/a-2751-2956
Further Publications
Diagnostic efficacy of pan-immune inflammation value for ulcerative colitis activity: a study based on multi-indicator comparison and diagnostic grey zone validation
BMC Gastroenterol
Xu S, Wen M, Yang A, Ma X, Dong J
doi: 10.1186/s12876-026-05082-z